Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Xuemei Wang, Ying Zhang, Yao Wu, Hongjing Cheng & Xueju Wang. (2023) The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy. Frontiers in Immunology 14.
Crossref
Crossref
Qing‐Dong Wang, Tao Shi, Yang Xu, Yang Liu & Mei‐Jia Zhang. (2023)
USP21
contributes to the aggressiveness of laryngeal cancer cells by deubiquitinating and stabilizing
AURKA
. The Kaohsiung Journal of Medical Sciences 39:4, pages 354-363.
Crossref
Crossref
Fabian Göricke, Victoria Vu, Leanna Smith, Ulrike Scheib, Raphael Böhm, Namik Akkilic, Gerd Wohlfahrt, Jörg Weiske, Ulf Bömer, Krzysztof Brzezinka, Niels Lindner, Philip Lienau, Stefan Gradl, Hartmut Beck, Peter J. Brown, Vijayaratnam Santhakumar, Masoud Vedadi, Dalia Barsyte-Lovejoy, Cheryl H. Arrowsmith, Norbert Schmees & Kirstin Petersen. (2023) Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21. Journal of Medicinal Chemistry 66:5, pages 3431-3447.
Crossref
Crossref
Qing‐Dong Wang, Li‐Li Liu, Di Li, Li Gao & Mei‐Jia Zhang. (2022) Salt‐like transcription factor 4 promotes laryngeal cancer progression through transcriptional activation of ubiquitin‐specific protease 21 to stabilize Yin Yang 1. Pathology International 73:3, pages 109-119.
Crossref
Crossref
Xiaofeng Li & Xia Li. (2023) USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1. Stem Cells International 2023, pages 1-11.
Crossref
Crossref
Yunlong Wu, Yuying Guo & Qiang Wang. (2022) USP21 accelerates the proliferation and glycolysis of esophageal cancer cells by regulating the STAT3/FOXO1 pathway. Tissue and Cell 79, pages 101916.
Crossref
Crossref
Qixiang Zhang, Zhengxin Chen, Qikai Tang, Zhangjie Wang, Jiacheng Lu, Yongping You & Huibo Wang. (2022) USP21 promotes self-renewal and tumorigenicity of mesenchymal glioblastoma stem cells by deubiquitinating and stabilizing FOXD1. Cell Death & Disease 13:8.
Crossref
Crossref
Tao An, Yanting Lu, Xu Yan & Jingjing Hou. (2022) Insights Into the Properties, Biological Functions, and Regulation of USP21. Frontiers in Pharmacology 13.
Crossref
Crossref
Jing Yang, Ellen L. Weisberg, Shuang Qi, Wei Ni, Husheng Mei, Zuowei Wang, Chengcheng Meng, Shengzhe Zhang, Mingqi Hou, Ziping Qi, Aoli Wang, Yunyun Jiang, Zongru Jiang, Tao Huang, Qingwang Liu, Robert S. Magin, Laura Doherty, Wenchao Wang, Jing Liu, Sara J. Buhrlage, Qingsong Liu & James D. Griffin. (2022) Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2. Leukemia 36:4, pages 1048-1057.
Crossref
Crossref
Hae-Seul Choi & Kwang-Hyun Baek. (2022) Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes. Cellular and Molecular Life Sciences 79:2.
Crossref
Crossref
Zhengliang Li, Xiaojing Liu, Haizhou Yu, Shaoping Wang, Shuliang Zhao & Guoxiang Jiang. (2021) USP21 regulates Hippo signaling to promote radioresistance by deubiquitinating FOXM1 in cervical cancer. Human Cell 35:1, pages 333-347.
Crossref
Crossref
Fu-Shun Hsu, Wei-Chou Lin, Kuan-Lin Kuo, Yen-Ling Chiu, Chen-Hsun Hsu, Shih-Ming Liao, Jun-Ren Dong, Shing-Hwa Liu, Shih-Chen Chang, Shao-Ping Yang, Yueh-Tang Chen, Ruei-Je Chang & Kuo-How Huang. (2021) PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. International Journal of Molecular Sciences 22:21, pages 11706.
Crossref
Crossref
Lucas Cruz, Paula Soares & Marcelo Correia. (2021) Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes. Pharmaceuticals 14:9, pages 848.
Crossref
Crossref
Qingqu Guo, Dike Shi, Lele Lin, Hongbo Li, Yunhai Wei, Baozhong Li & Dan Wu. (2021) De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Huixian Ma, Xiangrui Luo, Peng Zhou, Na He, Jun Zhou, Min Liu & Wei Xie. (2021) USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B‐cell lymphoma. Journal of Clinical Laboratory Analysis 35:3.
Crossref
Crossref
Chen-xi Zhao, Chen-ming Zeng, Ke Wang, Qiao-jun He, Bo Yang, Fan-fan Zhou & Hong Zhu. (2020) Ubiquitin–proteasome system-targeted therapy for uveal melanoma: what is the evidence?. Acta Pharmacologica Sinica 42:2, pages 179-188.
Crossref
Crossref
Yiqi Yang & Gang Li. (2020) Post-translational modifications of PRC2: signals directing its activity. Epigenetics & Chromatin 13:1.
Crossref
Crossref
Htoo Zarni Oo, Roland Seiler, Peter C. Black & Mads Daugaard. (2020) Post-translational modifications in bladder cancer: Expanding the tumor target repertoire. Urologic Oncology: Seminars and Original Investigations 38:12, pages 858-866.
Crossref
Crossref
Sun-Il Yun, Hye Kyung Hong, So-Young Yeo, Seok-Hyung Kim, Yong Beom Cho & Kyeong Kyu Kim. (2020) Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase. Cancers 12:1, pages 207.
Crossref
Crossref
Jae Eun Lee, Chan Mi Park & Jung Hwa Kim. (2020) USP7 deubiquitinates and stabilizes EZH2 in prostate cancer cells. Genetics and Molecular Biology 43:2.
Crossref
Crossref
Pei Xu, Haibo Xiao, Qi Yang, Rui Hu, Lianyong Jiang, Rui Bi, Xueyan Jiang, Lei Wang, Ju Mei, Fangbao Ding & Jianbing Huang. (2020) The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer. Experimental & Molecular Medicine 52:1, pages 41-55.
Crossref
Crossref
Boheng LiJunli YanThe PhyuShuangyi FanTae-Hoon ChungNurulhuda MustafaBaohong LinLingzhi Wang, Pieter Johan Adam Eichhorn, Boon-Cher GohSiok-Bian NgDennis Kappei & Wee-Joo Chng. (2019) MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma. Blood 134:23, pages 2046-2058.
Crossref
Crossref
Ji Cheng, Jianping Guo, Brian J. North, Bin Wang, Chun-Ping Cui, Hongchang Li, Kaixiong Tao, Lingqiang Zhang & Wenyi Wei. (2019) Functional analysis of deubiquitylating enzymes in tumorigenesis and development. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1872:2, pages 188312.
Crossref
Crossref
Pingping Hou, Xingdi Ma, Qiang Zhang, Chang-Jiun Wu, Wenting Liao, Jun Li, Huamin Wang, Jun Zhao, Xin Zhou, Carolyn Guan, Jeffery Ackroyd, Shan Jiang, Jianhua Zhang, Denise J. Spring, Y. Alan Wang & Ronald A. DePinho. (2019) USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation. Genes & Development 33:19-20, pages 1361-1366.
Crossref
Crossref
Swathi Ramakrishnan, Victoria Granger, Monika Rak, Qiang Hu, Kristopher Attwood, Lanni Aquila, Nithya Krishnan, Rafal Osiecki, Gissou Azabdaftari, Khurshid Guru, Gurkamal Chatta, Geraldine Gueron, Lacey McNally, Joyce Ohm, Jianmin Wang & Anna Woloszynska. (2019) Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death & Differentiation 26:10, pages 2100-2114.
Crossref
Crossref
Bandish B. Kapadia & Ronald B. Gartenhaus. (2019) DUBbing Down Translation: The Functional Interaction of Deubiquitinases with the Translational Machinery. Molecular Cancer Therapeutics 18:9, pages 1475-1483.
Crossref
Crossref
Fuwei Liu, Qian Fu, Yunpeng Li, Kai Zhang, Mingyue Tang, Wei Jiang, Bin Bo, Yajun Cui & Liang Kong. (2019) USP21 modulates Goosecoid function through deubiquitination. Bioscience Reports 39:7.
Crossref
Crossref
Jiabei He, Hong-Jen Lee, Suchandrima Saha, Diane Ruan, Hua Guo & Chia-Hsin Chan. (2019) Inhibition of USP2 eliminates cancer stem cells and enhances TNBC responsiveness to chemotherapy. Cell Death & Disease 10:4.
Crossref
Crossref
Li Ma, Kangyu Lin, Guoqiang Chang, Yiwen Chen, Chen Yue, Qing Guo, Sicong Zhang, Zhiliang Jia, Tony T. Huang, Aidong Zhou & Suyun Huang. (2019) Aberrant Activation of β-Catenin Signaling Drives Glioma Tumorigenesis via USP1-Mediated Stabilization of EZH2. Cancer Research 79:1, pages 72-85.
Crossref
Crossref
Nishi Kumari, Kwok Kin Lee & Sudhakar Jha. 2018. Neoplasm. Neoplasm.
Jianlin Wang, Zhaoping Qiu & Yadi Wu. (2018) Ubiquitin Regulation: The Histone Modifying Enzyme′s Story. Cells 7:9, pages 118.
Crossref
Crossref
Hung Thanh Nguyen, Jan-Michael Kugler, Anand C. Loya & Stephen M. Cohen. (2017) USP21 regulates Hippo pathway activity by mediating MARK protein turnover. Oncotarget 8:38, pages 64095-64105.
Crossref
Crossref